Research To Practice | Oncology Videos

Featuring perspectives from Drs Tanya Dorff and A Oliver Sartor, including the following topics: •       Introduction (0:00) •       Castration-Sensitive Prostate Cancer (5:26) •       PARP Inhibitors in Castration-Resistant Disease (23:00) •       Radiopharmaceuticals (39:46) CME information and select publications

Featuring perspectives from Drs Eric Lee, Neil Morganstein and Swati Vishwanathan, including the following topics: •       Gastroesophageal Cancers — Zev Wainberg, MD, MSc  o   Introduction (0:00) o   Systemic therapy considerations for HER2-negative localized gastroesophageal cancers (4:33) o   First-line systemic therapy for metastatic esophageal or gastric cancer (10:05) o   Zolbetuximab/chemot...

Oncology Today with Dr Neil Love: Special Edition — Current Management of Hepatobiliary Cancers — Dr Lipika Goyal Visit our website for more publications

Oncology Today with Dr Neil Love: Special Edition — Current Management of Hepatobiliary Cancers — Dr Zev Wainberg Visit our website for more publications

Featuring perspectives from Dr Sara Tolaney, including the following topics: •       Introduction (00:00) •       Case: A premenopausal woman in her early 30s with T1c N0 ER/PR-positive, HER2-negative, gBRCA2-mutant invasive ductal carcinoma (IDC) with an Oncotype DX® Recurrence Score® (RS) of 30 receives adjuvant chemotherapy followed by leuprolide/letrozole but wishes to discontinue treatment to...

Featuring perspectives from Dr Matthew Galsky, Jonathan Rosenberg, and Dr Arlene Siefker-Radtke, moderated by Dr Elisabeth Heath, including the following topics: •       Integrating Novel Treatment Strategies into the Management of Nonmetastatic Urothelial Bladder Cancer (UBC) — Dr Galsky o   Introduction (00:00) o   Case: A man in his late 70s with superficial transitional cell carcinoma of the b...

Featuring perspectives from Dr Emmanuel Antonarakis, Prof Karim Fizazi, Dr Maha Hussain and Dr Matthew Smith, moderated by Dr Alan Bryce, including the following topics: •        Management Approaches for Nonmetastatic Prostate Cancer — Dr Bryce o   Introduction (00:00) o   Case: A man in his early 70s with Gleason 8 prostate cancer after EBRT and leuprolide/enzalutamide, now receiving leuprolide/...

Featuring an interview with Drs Gottfried Konecny and Chirag Patel, including the following topics: •       Tumor Treating Fields with Chirag B Patel, MD, PhD  o   Introduction (0:00) o   Mechanism of action of tumor treating fields (5:53) o   Tumor treating fields for glioblastoma multiforme (25:08) o   Tumor treating fields for other tumor types (28:50) o   Case presentations (34:10) •       Upd...

Featuring perspectives from Dr Richard Finn, Dr Lipika Goyal and Prof Arndt Vogel, moderated by Dr Katie Kelley, including the following topics: •       First-Line Treatment for Advanced Hepatocellular Carcinoma (HCC) — Dr Finn  o   Introduction (0:00) o   Case: A man in his early 70s with newly diagnosed metastatic HCC receives atezolizumab/bevacizumab — Warren S Brenner, MD (2:27)) o   Case: A w...

Proceedings from a symposium in partnership with NCOA and SCOS, featuring perspectives from Drs Ibiayi Dagogo-Jack and Stephen V Liu on recent advances and real-world implications in lung cancer. CME information and select publications

Proceedings from a symposium in partnership with NCOA and SCOS, featuring perspectives from Drs Michael Birrer and Ursula Matulonis on recent advances and real-world implications in gynecologic cancers. CME information and select publications

Proceedings from a symposium in partnership with NCOA and SCOS, featuring perspectives from Drs Danielle Brander and Craig Moskowitz on recent advances and real-world implications in chronic lymphocytic leukemia and lymphomas. CME information and select publications

Proceedings from a symposium in partnership with NCOA and SCOS, featuring perspectives from Drs Daniel Petrylak and Sandy Srinivas on recent advances and real-world implications in genitourinary cancers. CME information and select publications

Proceedings from a symposium in partnership with NCOA and SCOS, featuring perspectives from Drs Tanios Bekaii-Saab and Rutika Mehta on recent advances and real-world implications in gastrointestinal cancers. CME information and select publications

Proceedings from a symposium in partnership with NCOA and SCOS, featuring perspectives from Drs Harold Burstein and Virginia Kaklamani on recent advances and real-world implications in breast cancer. CME information and select publications

Featuring perspectives from Prof Laurence Albiges, Dr Toni Choueiri and Prof Thomas Powles, moderated by Dr Brian Rini, including the following topics: •       Available Data with and Ongoing Investigation of Immune Checkpoint Inhibitors for Nonmetastatic Renal Cell Carcinoma (RCC) — Prof Powles  o   Introduction (0:00) o   Case: A woman in her early 60s after left nephrectomy (T3aN0M0 clear cell...

Featuring perspectives from Dr Christopher Lieu, including the following topics: •        Early-Onset Colorectal Cancer o   Introduction (00:00) •       Localized Disease o   Case: A woman in her mid 30s with left-sided T3N0 Grade II obstructing adenocarcinoma of the colon — William R Mitchell, MD (16:31) o   Case: A woman in her early 50s with Stage II mismatch repair-proficient sigmoid colon can...

Inside the Issue — Exploring the Current Role of Ovarian Suppression in the Management of Breast Cancer | Faculty Presentation 2: Tolerability and Other Practical Issues with OFS, Including Its Potential Utility in Preserving Fertility — Dr Ann Patridge CME information and select publications

Inside the Issue — Exploring the Current Role of Ovarian Suppression in the Management of Breast Cancer | Faculty Presentation 1: Optimizing the Use of Ovarian Function Suppression (OFS)/Ablation in the Care of Patients with Breast Cancer — Dr Kathy Miller CME information and select publications

Featuring perspectives from Dr Matthew Lunning, including the following topics: ·      Introduction (00:00) ·      Case: A woman in her mid 20s with T1cN0M0, ER/PR-positive, HER2-negative breast cancer, Recurrence Score® (RS) of 26 — Dr Partridge (10:03) ·      Case: A woman in her late 20s with a 2.8-cm ER/PR-positive, HER2-positive Grade III intraductal carcinoma — Dr Miller (26:42) ·      Case:...

Featuring perspectives from Dr Yelena Janjigian, Prof Florian Lordick and Dr Zev Wainberg, moderated by Dr Samuel Klempner, including the following topics: •       Optimizing the Selection of Therapy for Newly Diagnosed Advanced Gastric or Gastroesophageal Junction (GEJ) Cancer — Dr Klempner o   Introduction (0:00) o   Case: A man in his mid 50s with HER2-negative gastroesophageal adenocarcinoma (...

Featuring perspectives from Dr D Ross Camidge, Dr Justin Gainor, Prof Benjamin Solomon and Prof Solange Peters, including the following topics: •       Evolving Understanding and Management of Non-Small Cell Lung Cancer (NSCLC) with Targeted Mutations (0:00) •       Adjuvant Therapy for Patients with NSCLC with Targetable Mutations (11:17) •       Family Planning for Patients with Cancer (23:50) •...

Featuring perspectives from Dr Matthew Lunning, including the following topics: •       Potential role of polatuzumab vedotin/R-CHP in therapy for previously untreated diffuse large B-cell lymphoma (DLBCL) (00:00) •       Association between metabolic tumor volume and clinical outcomes with loncastuximab tesirine in the LOTIS-2 trial and axicabtagene ciloleucel in the ZUMA-7 trial (10:54) •      ...

Featuring a slide presentation and related discussion from Dr Mrinal Gounder, including the following topics: •       Efficacy and tolerability of sorafenib in patients with advanced and refractory desmoid tumors (00:00) •       DESMOPAZ: Results of a Phase II trial of pazopanib versus IV methotrexate/vinblastine for progressive desmoid tumors (1:59) •       Results of the pivotal Phase III DeFi t...

Featuring perspectives from Dr Mrinal Gounder, including the following topics: •       Incidence and prevalence of desmoid tumors (00:00) •       Outcomes associated with historical management paradigms for desmoid tumors (17:15) •       Rationale for targeting the gamma secretase complex and Notch pathway as a therapeutic approach for desmoid tumors; mechanism of action of nirogacestat (20:56) •...